AI-generated summary
The authors ran a double-blind, sham-controlled pilot trial of transcranial near-infrared light therapy added to usual care in adults with major depressive disorder, treated twice weekly for eight weeks. They report a medium to large antidepressant effect on the Hamilton Depression Rating Scale and few serious adverse events. The small sample size means replication is needed.
- Participants
- 21
- Who or what was studied
- Subjects with major depressive disorder
- Wavelengths
- 823 nm
- Limits stated in the abstract
- The authors state the sample was small and that replication is warranted.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 823 nm
- Energy density (fluence)
- 65.2 J/cm2
- Power density (irradiance)
- 36.2 mW/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Near-infrared, Transcranial photobiomodulation, Effect size, Oxidative stress, Neuroplasticity, Inflammation, Mitochondria. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.